Home β€Ί Stock analysis β€Ί RFL

Rafael (RFL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)

Updated Oct 16, 2026, 4:00 PM ET

What changed since yesterday

RFL slides 5.4% to $1.39. Closed at $1.39, -5.44% vs the prior close of $1.47. Day range $1.37–$1.47, opened at $1.44.

Last close$1.39-5.44%
Day range1.37–1.47
Open1.44
Volume30.53K
52-week range1.12–3.96
Avg volume (20d)236.59K

RFL daily analysis β€” what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 16, 2026 β€” RFL slides 5.4% to $1.39
Oct 15, 2026 β€” RFL rises 2.8% to $1.47
Oct 14, 2026 β€” RFL slides 4.0% to $1.43, 3 down days in a row
Oct 13, 2026 β€” RFL dips 2.0% to $1.49
Oct 12, 2026 β€” RFL slides 5.0% to $1.52
Oct 9, 2026 β€” RFL jumps 8.1% to $1.60
Oct 8, 2026 β€” RFL ends flat (+0.0%) to $1.48
Oct 7, 2026 β€” RFL dips 0.7% to $1.48
Oct 6, 2026 β€” RFL rises 1.4% to $1.49
Oct 5, 2026 β€” RFL slides 4.5% to $1.47
Oct 2, 2026 β€” RFL rises 2.7% to $1.54

RFL latest news & SEC filings

Every SEC filing by or about RFL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Sep 30, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-104876

Sep 23, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-399248

Jul 31, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-328798

Jul 8, 2026 Β· Form 8-K β€” Major event / current report

Current report β€” a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001213900-26-076411

Jun 23, 2026 Β· Form 4 β€” Insider trade

Insider trade report (Form 4) β€” a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-279350

Things to know before you trade RFL

RFL market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 16, 20261.441.471.371.3930.53K
Oct 15, 20261.431.541.401.4771.20K
Oct 14, 20261.401.491.381.4347.90K
Oct 13, 20261.521.571.431.4928.00K
Oct 12, 20261.581.631.501.5239.20K
Oct 9, 20261.501.621.501.6093.90K
Oct 8, 20261.461.521.461.48148.50K
Oct 7, 20261.461.521.441.4855.40K
Oct 6, 20261.481.521.441.49133.50K
Oct 5, 20261.541.571.461.47106.10K
Oct 2, 20261.521.561.471.54178.20K
Oct 1, 20261.321.521.281.50504.10K
Sep 30, 20261.551.551.201.322.29M
Sep 29, 20262.042.142.002.0385.30K
Sep 28, 20261.912.191.912.0265.80K
Sep 25, 20261.932.041.931.9448.90K
Sep 24, 20262.002.041.841.91595.90K
Sep 23, 20262.012.061.972.0271.30K
Sep 22, 20261.972.101.972.00101.10K
Sep 21, 20262.042.091.962.0040.20K

About Rafael

Rafael (RFL) is listed on the NYSE and classified by the SEC under β€œPharmaceutical Preparations”. Its business address is in NEWARK, NJ. State of incorporation: DE. Fiscal year ends July 31. SEC CIK 1713863.

RFL board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Alan GraysonDirectorJan 29, 2026
Howard S JonasExec Chairman, CEO & PresidentJul 31, 2026
Mark N SteinDirectorJan 29, 2026
Markus SiegerDirectorJan 30, 2026
Michael J WeissDirectorJan 29, 2026

Executive officers

NameTitleLatest filing
Howard S JonasExec Chairman, CEO & PresidentJul 31, 2026
David PolinskyChief Financial OfficerSep 23, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
No open-market insider buys or sales reported in the last 12 months.

RFL financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Jul 31, 2025$30.00K$-30.52M-1.04$-18.92M
Jul 31, 2024β€”$-34.41M-1.45$-7.80M
Jul 31, 2023β€”$-1.88M-0.08$-10.89M
Jul 31, 2022β€”$-124.66M-6.31$-26.08M
Jul 31, 2021β€”$-23.06M-1.49$-15.60M

Latest balance sheet: total assets $91.99M, total liabilities $11.19M, cash $30.50M (as of Apr 30, 2026).

RFL earnings / results-day log

DateFilingClose that day
Jun 11, 20268-K Item 2.02 (results)$2.12
Mar 16, 20268-K Item 2.02 (results)$1.31
Dec 11, 20258-K Item 2.02 (results)$1.49
Oct 29, 20258-K Item 2.02 (results)$1.34
Jun 11, 20258-K Item 2.02 (results)$2.06
Mar 14, 20258-K Item 2.02 (results)$1.80
Dec 11, 20248-K Item 2.02 (results)$1.86
Nov 7, 20248-K Item 2.02 (results)$1.87
Jun 14, 20248-K Item 2.02 (results)β€”
Mar 14, 20248-K Item 2.02 (results)β€”
Dec 14, 20238-K Item 2.02 (results)β€”
Oct 30, 20238-K Item 2.02 (results)β€”

Related stocks Β· Pharmaceutical Preparations

Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)

Popular today

Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)

More on RFL

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.